tesamorelin ipamorelin peptide blend 6mg | 2mg TESA+IPA BLEND 10/3MG - Planet

CJC-1295 and ipamorelin are commonly used together because they have complementary time-release characteristics: CJC-1295 is effectively GHRH that has been modified to have a longer half-life, so it stimulates pituitary growth hormone secretion in a sustained manner over an extended period.9 Ipamorelin acts on the pituitary gland directly, inducing a more immediate dump of growth hormone into circulation

In general, CJC-1295 is often used in cycles ranging from 8-12 weeks, followed by a break

A single consultation can cut through the noise

Divide the vial strength of 10 mg by the amount you use per injection

The information on this site is not a substitute for professional medical advice

Risks: Combination Protocol Analysis Building on safety data and protocol design considerations, its time to weigh the benefits and risks of combining tesamorelin with CJC-1295/ipamorelin